![]() |
|
|
Vol. 282, Issue 2, 715-726, 1997
Groningen Institute for Drug Studies (GIDS),4
University Centre for Pharmacy, Department of Pharmacokinetics and Drug
Delivery, University of Groningen, Groningen, The Netherlands (J.H.P.,
J.R., D.K.F.M.); and
Research Group for Experimental Anesthesiology and
Clinical Pharmacology, University Hospital, Department of
Anesthesiology, Groningen, The Netherlands (J.H.P., J.R., J.M.K.H.W.)
To obtain more insight in the relationship between physicochemical
properties of cationic drugs and their hepatobiliary transport rate, a
series of 12 aminosteroidal neuromuscular blocking agents (NMBAs),
supplemented with data of four related NMBAs from the literature, were
investigated in the isolated perfused rat liver. A significant
correlation was found between plasma protein binding and the partition
coefficient octanol/Krebs (log P), confirming results from the
literature with other organic cations. Evidence was found for a
saturable hepatic uptake of several NMBAs, indicating that
carrier-mediated uptake processes are involved. Hepatic uptake rate was
closely related to the lipophilicity of the compounds; the initial
extraction ratio, the apparent clearance and the intrinsic clearance
were significantly correlated to log P. We did not find a significant
correlation between biliary clearance and lipophilicity in the current
series of compounds. Pharmacokinetics analysis of perfusate
disappearance and biliary excretion data revealed that a considerable
fraction of the dose of these bulky organic cations is stored in the
liver and seems to not be directly available for biliary excretion.
This finding is in line with earlier observations showing a pronounced
accumulation of this type of compounds in mitochondria and lysosomes.
This article has been cited by other articles:
![]() |
J. J. Roy and F. Varin Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship Br. J. Anaesth., August 1, 2004; 93(2): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Siebert, D. Y. Hung, P. Chang, and M. S. Roberts Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, I. Ramzan, and B. Baker Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function{dagger}{ddagger} Br. J. Anaesth., June 1, 2002; 88(6): 764 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Moore and J. M. Hunter The new neuromuscular blocking agents: do they offer any advantages? Br. J. Anaesth., December 1, 2001; 87(6): 912 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. van Montfoort, M. Muller, G. M. M. Groothuis, D. K. F. Meijer, H. Koepsell, and P. J. Meier Comparison of ""Type I"" and ""Type II"" Organic Cation Transport by Organic Cation Transporters and Organic Anion-Transporting Polypeptides J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 110 - 115. [Abstract] [Full Text] |
||||
![]() |
D. Y. Hung, P. Chang, M. Weiss, and M. S. Roberts Structure-Hepatic Disposition Relationships for Cationic Drugs in Isolated Perfused Rat Livers: Transmembrane Exchange and Cytoplasmic Binding Process J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 780 - 789. [Abstract] [Full Text] |
||||
![]() |
J. H. Proost, L. I. Eriksson, R. K. Mirakhur, G. Roest, and J. M. K. H. Wierda Urinary, biliary and faecal excretion of rocuronium in humans Br. J. Anaesth., November 1, 2000; 85(5): 717 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ishizaki, K. Yokogawa, F. Ichimura, and S. Ohkuma Uptake of Imipramine in Rat Liver Lysosomes In Vitro and Its Inhibition by Basic Drugs J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1088 - 1098. [Abstract] [Full Text] |
||||
![]() |
J. H. Proost, J. M. K. H. Wierda, M. C. Houwertjes, J. Roggeveld, and D. K. F. Meijer Structure-Pharmacokinetics Relationship of Series of Aminosteroidal Neuromuscular Blocking Agents in the Cat J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 861 - 869. [Abstract] [Full Text] |
||||
![]() |
J. E. van Montfoort, B. Hagenbuch, K. E. Fattinger, M. Müller, G. M. M. Groothuis, D. K. F. Meijer, and P. J. Meier Polyspecific Organic Anion Transporting Polypeptides Mediate Hepatic Uptake of Amphipathic Type II Organic Cations J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 147 - 152. [Abstract] [Full Text] |
||||
![]() |
L. Zhang, W. Gorset, M. J. Dresser, and K. M. Giacomini The Interaction of n-Tetraalkylammonium Compounds with a Human Organic Cation Transporter, hOCT1 J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1192 - 1198. [Abstract] [Full Text] |
||||
![]() |
S. Schiere, J. H. Proost, M. Schuringa, and J. M. K. H. Wierda Pharmacokinetics and Pharmacokinetic-Dynamic Relationship Between Rapacuronium (Org 9487) and Its 3-Desacetyl Metabolite (Org 9488) Anesth. Analg., March 1, 1999; 88(3): 640 - 640. [Abstract] [Full Text] [PDF] |
||||